Submitted by dcc on Mon, 2020-11-30 14:12 Study Title: A Pilot Study of Dinutuximab, Sargramostim (GM-CSF), and Isotretinoin in Combination with Irinotecan and Temozolomide in the Post-Consolidation Setting for High-Risk NeuroblastomaCIRB: Pediatric CIRBLead Group: COGStatus: ActiveReview Status: Available to Open
